-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – EP-547 in Uremic (Renal) Pruritus
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - EP-547 in Uremic (Renal) Pruritus report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. EP-547 in Uremic (Renal) Pruritus Drug Details: EP-547 is under...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – EP-0057 in Epithelial Ovarian Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - EP-0057 in Epithelial Ovarian Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. EP-0057 in Epithelial Ovarian Cancer Drug Details: EP-0057 (NLG-207, CRLX-101)...
-
Product Insights
Epping Forest/ Place Leisure – Epping Leisure Center – Essex
The Epping Forest/ Place Leisure – Epping Leisure Center – Essex involves the construction of a leisure center in Colchester, Essex, England, the UK. Equip yourself with the essential tools needed to make informed and profitable decisions with our Epping Forest/ Place Leisure – Epping Leisure Center – Essex report. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business days of the purchase, excluding weekends and holidays....
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – EP-0057 in Small-Cell Lung Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - EP-0057 in Small-Cell Lung Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. EP-0057 in Small-Cell Lung Cancer Drug Details: EP-0057 (NLG-207, CRLX-101)...
-
Product Insights
NewShanghai MicroPort EP MedTech Co Ltd Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our Shanghai MicroPort EP MedTech Co Ltd Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. Shanghai MicroPort EP MedTech Co Ltd (MicroPort EP) is a medical device company that develops and markets devices and equipment for cardiac electrophysiological interventional therapy. GlobalData's Medical Devices company profile report, “Shanghai MicroPort EP MedTech Co Ltd Pipeline Insight and Competitive Landscape, 2023" provides information about the company overview and analysis on their pipeline products. This...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – EP-0057 in Transitional Cell Carcinoma (Urothelial Cell Carcinoma)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - EP-0057 in Transitional Cell Carcinoma (Urothelial Cell Carcinoma) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. EP-0057 in Transitional Cell Carcinoma (Urothelial Cell...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – EP-0057 in Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - EP-0057 in Metastatic Castration-Resistant Prostate Cancer (mCRPC) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. EP-0057 in Metastatic Castration-Resistant Prostate Cancer (mCRPC) Drug...
-
Product Insights
NewImricor Medical Systems Inc Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our Imricor Medical Systems Inc Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. Imricor Medical Systems Inc (Imricor Medical) is a medical device company that offers MRI equipment. The company offers products such as cardiac ablation systems, vision MR EP ablation catheter and horizon MR EP recording system. Its vision MR EP ablation catheter is used to operate in a MRI room; and Horizon MR EP recording system performs recording and...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Bitopertin in Anemia
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Bitopertin in Anemia report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Bitopertin in Anemia Drug Details: Bitopertin is under development for the treatment...